GPT and metabolic dysfunction-associated steatotic liver disease: For example, alanine transaminase (ALT) was reported to be increased in NAFLD patients in 72% of the studies included in the analysis, whereas only 6% of the studies reported increases in alkaline phosphatase (ALP) and c-peptide.